Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Description of the Spectrum of Choroidal Involvement in 245 Patients with Tubercular Uveitis.
Agrawal R, Gunasekeran DV, Agarwal A, Carreño E, Aggarwal K, Gupta B, Raje D, Murthy SI, Westcott M, Chee SP, McCluskey P, Ling HS, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, González-López JJ, Androudi S, Bansal R, Moharana B, Mahajan S, Esposti S, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Lord J, Singh R, Sharma A, Sharma K, Zierhut M, Kon OM, Kempen J, Cunningham ET, Rousselot A, Nguyen QD, Pavesio C, Gupta V. Agrawal R, et al. Among authors: zierhut m. Ocul Immunol Inflamm. 2020 Sep 30;28(sup1):38-48. doi: 10.1080/09273948.2018.1489061. Epub 2018 Aug 29. Ocul Immunol Inflamm. 2020. PMID: 30156979
Therapy of ocular Behçet disease.
Zierhut M, Abu El-Asrar AM, Bodaghi B, Tugal-Tutkun I. Zierhut M, et al. Ocul Immunol Inflamm. 2014 Feb;22(1):64-76. doi: 10.3109/09273948.2013.866257. Epub 2013 Dec 30. Ocul Immunol Inflamm. 2014. PMID: 24377434 Review.
The promise and limitations of TNF-α inhibition for uveitis.
Cunningham ET Jr, Zierhut M. Cunningham ET Jr, et al. Among authors: zierhut m. Ocul Immunol Inflamm. 2014 Apr;22(2):87-9. doi: 10.3109/09273948.2014.894766. Ocul Immunol Inflamm. 2014. PMID: 24689529 No abstract available.
Uveitis in Children and Adolescents.
Cunningham ET Jr, Smith JR, Tugal-Tutkun I, Rothova A, Zierhut M. Cunningham ET Jr, et al. Among authors: zierhut m. Ocul Immunol Inflamm. 2016 Aug;24(4):365-71. doi: 10.1080/09273948.2016.1204777. Ocul Immunol Inflamm. 2016. PMID: 27471956 No abstract available.
Behçet Uveitis.
Cunningham ET Jr, Tugal-Tutkun I, Khairallah M, Okada AA, Bodaghi B, Zierhut M. Cunningham ET Jr, et al. Among authors: zierhut m. Ocul Immunol Inflamm. 2017 Feb;25(1):2-6. doi: 10.1080/09273948.2017.1279840. Ocul Immunol Inflamm. 2017. PMID: 28195819 No abstract available.
Multiple Sclerosis-Associated Uveitis.
Cunningham ET Jr, Pavesio CE, Goldstein DA, Forooghian F, Zierhut M. Cunningham ET Jr, et al. Among authors: zierhut m. Ocul Immunol Inflamm. 2017 Jun;25(3):299-301. doi: 10.1080/09273948.2017.1334469. Ocul Immunol Inflamm. 2017. PMID: 28696171 No abstract available.
Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1.
Agrawal R, Gunasekeran DV, Grant R, Agarwal A, Kon OM, Nguyen QD, Pavesio C, Gupta V; Collaborative Ocular Tuberculosis Study (COTS)–1 Study Group. Agrawal R, et al. JAMA Ophthalmol. 2017 Dec 1;135(12):1318-1327. doi: 10.1001/jamaophthalmol.2017.4485. JAMA Ophthalmol. 2017. PMID: 29075752 Free PMC article.
The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: Polymerase Chain Reaction in the Diagnosis and Management of Tubercular Uveitis: Global Trends.
Agarwal A, Agrawal R, Gunasekaran DV, Raje D, Gupta B, Aggarwal K, Murthy SL, Westcott M, Chee SP, McCluskey P, Ling HS, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P, Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, Carreño E, Lee R, Al-Dhibi H, Bodaghi B, Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, González-López JJ, Androudi S, Bansal R, Moharana B, Mahajan S, Esposti S, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R, Singh R, Sharma A, Sharma K, Zierhut M, Kon OM, Cunningham E, Nguyen QD, Pavesio C, Gupta V. Agarwal A, et al. Among authors: zierhut m. Ocul Immunol Inflamm. 2019;27(3):465-473. doi: 10.1080/09273948.2017.1406529. Epub 2017 Dec 20. Ocul Immunol Inflamm. 2019. PMID: 29261089 Free article.
Uveitic Ocular Hypertension and Glaucoma.
Cunningham ET Jr, Zierhut M. Cunningham ET Jr, et al. Among authors: zierhut m. Ocul Immunol Inflamm. 2017 Dec;25(6):737-739. doi: 10.1080/09273948.2017.1415077. Ocul Immunol Inflamm. 2017. PMID: 29265966 No abstract available.
Design and Interpretation of Clinic-Based Studies in Uveitis.
Cunningham ET Jr, Acharya N, Kempen JH, Zierhut M. Cunningham ET Jr, et al. Among authors: zierhut m. Ocul Immunol Inflamm. 2015 Aug;23(4):267-270. doi: 10.3109/09273948.2015.1074028. Ocul Immunol Inflamm. 2015. PMID: 29265967 No abstract available.
344 results